Can HPV vaccines eliminate genital warts?
HPV vaccines and their impact on clinical outcomes are discussed by Dr Grace Lee, Deputy Director Goodfellow Unit and Associate Professor Nikki Turner, academic General Practitioner and the Director of the Immune Advisory Centre.
Topics covered include:
- The risks of HPV infection and clinical outcomes. Recognition of HPV as a major causal agent of multiple cancers.
- An overview of HPV vaccines.
- HPV vaccine effectiveness: impact on genital warts and precancerous cervical lesions.
- Vaccine safety and common HPV vaccine myths.
Resources
- Gardasil 9 IMAC
- Human papillomavirus (HPV) IMAC
- What's new in sexual health with Nicky Perkins Goodfellow podcast (2019)
- Access to HPV vaccine widened BPAC (2016)
- Questions and answers about HPV immunisation NZ MOH Patient information
- Human papillomavirus (HPV) Health Navigator NZ Patient resources
- HPV NZ Project website
Peer group discussion points |
During the MedTalk, Nikki discussed the risks of HPV infection and the wide array of clinical pathology HPV can cause, alongside the impact of vaccination on some of these clinical outcomes.
As highlighted during the interview, there continues to be equity issues with Maori women having an incidence of cervical cancer 2-3 times higher than other groups.
We have a safe and effective vaccine that is now available. As primary health care providers we have an important role in vaccine education.
|
This MedTalk is supported by
Date Published:
Monday, March 4, 2019
This presentation is intended for qualified health practitioners professional development and should not be relied upon for any other purpose. Any opinions offered are those of the presenter or other speaker and do not necessarily represent the views of Goodfellow Unit.